Overexpression of tenascin-C (TN-C) in breast carcinomas has been associated with a migratory or even invasive tumor cell phenotype. The mechanisms regulating expression and matrix deposition of TN-C in normal and cancerous breast tissues are, however, little understood. Here, we demonstrate that mouse mammary epithelial cells (EpH4) transformed by oncogenic Ha-Ras (EpRas) overexpress TN-C, which accumulates in the cytoplasm. When EpRas cells undergo epithelial-mesenchymal transition (EMT) in response to TGFb1, they secrete TN-C into the culture medium. In EpRas cells undergoing TGFb1-induced EMT in three-dimensional (3D)-collagen gel cultures, TN-C was deposited into an extracellular matrix (ECM) already containing fibronectin and perlecan. Under less physiological 2D plastic cultures, EpRas cells undergoing EMT failed to deposit TN-C into an (apparently incomplete) ECM. Ras-downstream signaling was dissected by pharmacological inhibitors and effectorspecific Ras mutants (V12S35, V12C40), specifically inhibiting or activating ERK/MAPK or PI3K signaling, respectively. We showed that TN-C overexpression required a hyperactive ERK/MAPK-signaling pathway, while elevated PI3K signaling did not enhance TN-C expression. Similarly, tumors induced by cells exhibiting hyperactive ERK/MAPK signaling showed expression of TN-C in the tumor cells themselves, while only endothelial cells expressed TN-C in tumors caused by the V12C40 mutant (incapable of EMT in vivo). Taken together, our data indicate that hyperactive ERK/MAPK signaling causes enhanced expression of TN-C, while its secretion is induced by TGFb1 and both signals cooperate in TN-C matrix deposition. Importantly, both signals also cooperate to induce EMT in vitro and tumor progression/ metastasis in vivo.
Introduction
Tenascin-C (here referred to as TN-C) is a large, hexameric extracellular matrix (ECM) protein associated with epithelial-mesenchymal interactions during embryogenesis (Chiquet-Ehrismann et al., 1986) . Expression of TN-C is highly restricted in normal adult tissues but is increased during wound healing and under many pathological conditions. In carcinomas, TN-C is usually expressed in the tumor stroma, and also in the tumor cells themselves (for a review, see Jones and Jones, 2000a) , and in the vasculature at sites of angiogenesis (Tokes et al., 1999; Zagzag et al., 2002) . These data suggest that TN-C functions primarily in processes during which ECM remodeling takes place.
TN-C significantly inhibits adhesion of cells to a fibronectin (FN)-containing ECM by preventing the interaction of FN with syndecan-4 and stimulates the proliferation of cancer cells Huang et al., 2001; Chiquet-Ehrismann and Chiquet, 2003) , which also significantly stimulates migratory behavior. TN-C transiently induces phosphorylation of focal adhesion kinase (FAK) and 14-3-3 tau expression, the latter regulating cell growth and oncogenic transformation (Midwood and Schwarzbauer, 2002; Martin et al., 2003) . The effect of TN-C depends on the cell type and other components present in the ECM (for a review, see Jones and Jones, 2000a) . TN-C gene expression is stimulated by various growth factors, cytokines and tumor promoters Rettig et al., 1994; Jones and Jones, 2000b) . For instance, epidermal growth factor (EGF) induces TN-C via its receptor (EGFR, Sakai et al., 1995) , which activates Ras-downstream signaling. Ras signaling seems to be important for TN-C upregulation, since normal melanocytes fail to express TN-C in response to basic FGF, but do so after Ras-induced oncogenic transformation (Rettig et al., 1994) . Moreover, transient overexpression of the Ha-Ras oncoprotein stimulates TN-C expression in rat fibroblasts (Mettouchi et al., 1997) . In turn, EGF-like repeats of human TN-C activate the EGFR and thus elicit mitogenesis in NR6 fibroblasts via Ras/MAPK signaling (Swindle et al., 2001) .
Breast cancers frequently overexpress EGFR2, likely to cause Ras hyperactivation. Oncogenic, mutated forms of Ras (Harvey-, Kirsten-and N-isoforms) are detected in at least 30% of all human cancers (Bos, 1989) and in 5% of breast cancers (Miyakis et al., 1998) . Mammary tumor cells also produce transforming growth factor b1 (TGFb1), which can induce TN-C expression in the surrounding stroma (ChiquetEhrismann et al., 1989) . TGFb1 and its receptors have recently gained attention as signaling pathways contributing to metastatic behavior in various carcinoma cells Derynck et al., 2001; Akhurst, 2002; Roberts and Wakefield, 2003) . It is unclear, however, whether or not TGFb signaling contributes to overexpression of TN-C found in tumors and mammary carcinoma cell lines.
While TN-C is expressed only at very low levels in the normal mammary gland (depending on the menstrual cycle), mammary carcinoma tissues are rich sources of TN-C, which is produced by both stromal and tumor cells (Yoshida et al., 1997; Adams et al., 2002) . Furthermore, normal and transformed mammary epithelial cell lines secrete TN-C (Lightner et al., 1994; Wirl et al., 1995; Dandachi et al., 2001) . TN-C might contribute to tumor cell proliferation, migration (Chiquet-Ehrismann et al., 1986; Deryugina and Bourdon, 1996) and angiogenesis (Canfield and Schor, 1995; Zagzag et al., 2002) . In addition, a correlation exists between TN-C expression in cancer cells at the invasion front, a higher proliferation rate measured by Ki67 and metastasis to distant sites (Jahkola et al., 1998; Nagata et al., 2003; Tsunoda et al., 2003) .
The studies described here employed EpH4 cells, a combined in vitro/in vivo cell model consisting of fully polarized mammary epithelial cells isolated from midpregnant mice (Reichmann et al., 1989; Fialka et al., 1996) . These cells are nontumorigenic, and respond to TGFb1 with growth arrest and apoptosis. Ras transformation only marginally affects the polarized EpH4 phenotype, but renders these cells (EpRas) tumorigenic and protects them from TGFb1-induced cell cycle arrest and apoptosis. Both in vitro and in vivo, TGFb1 causes EpRas cells to undergo epithelial-mesenchymal transition (EMT). This phenotype is characterized by a fibroblastoid morphology, loss of epithelial (e.g. Ecadherin) and gain of mesenchymal markers (vimentin), and is stabilized by an autocrine TGFb1 loop Janda et al., 2002a) . Both EMT in vitro and metastasis formation in mice were shown to require cooperation between TGFb1 signaling and a hyperactive ERK/MAPK-signaling pathway (Oft et al., , 1998 Janda et al., 2002a) . Accordingly, TGFb1 signaling confers metastatic potential onto tumors in vivo (Weeks et al., 2001; Muraoka et al., 2002; Yang et al., 2002) .
In this paper, the EpH4/EpRas cell system was used to address a possible contribution of TN-C to the metastatic phenotype of these cells, confirming a role for oncogenic Ras in TN-C expression. The ERK/MAPK signaling pathway was important for TN-C expression, while ERK/MAPK-hyperactivation and TGFb1 signaling cooperated in enhancing secretion of TN-C during EMT. Using ERK/MAPK versus PI3K-specific Raseffector mutants and an in vivo tumorigenesis model, we could confirm our in vitro data. Thus we propose a tumor-promoting role of TN-C overexpression.
Results

Tenascin-C expression is downregulated in EpH4 cells upon epithelial polarisation
Mammary epithelial cells of rat and mouse origin cease to produce TN-C protein expression when grown in dense monolayers on plastic (Wirl et al., 1995) . We analysed density-dependent TN-C gene expression in EpH4 cells, which form hemicysts in postconfluent cultures, due to their ability to polarize fully in vitro. Using a cDNA probe for mouse TN-C in Northern blots, we detected one single TN-C splice variant of approximately 7.5 kb in RNA preparations derived from subconfluent cells (Figure 1a ). In contrast, RNA from highly polarized, postconfluent cells after 4 or 6 days on dishes contains undetectable levels of TN-C mRNA. Since EpH4 cells almost exclusively secrete TN-C, we analysed TN-C protein in conditioned media from similar cultures by Western blot analysis. This clearly confirmed the Northern blot data, showing a clear reduction of secreted TN-C protein in postconfluent cultures of EpH4 cells ( Figure 1b) .
As shown by immunofluorescence, subconfluent cultures of EpH4 cells expressed TN-C in nearly all cells, revealing a granular, cytoplasmic distribution. In contrast, only a few cells showed a TN-C signal in cultures 3 days after seeding, and fully polarized cells forming hemicysts were negative for TN-C fluorescence (data not shown). Conditioned culture media from subconfluent cultures of EpH4 cells showed a single Figure 1 EpH4 cells downregulate TN-C upon confluency. (a) EpH4 cells were plated at a concentration of 2 Â 10 5 cells per 3.5 cm dish, grown for 1, 2, 4 and 6 days and extracts prepared for Northern blotting, using a probe for mouse TN-C mRNA. (b) Conditioned medium from similar cultures was also analysed for secreted TNC by Western blot analysis. Cells became E80% confluent on day 2 and were postconfluent (including dome (hemicyst) formation at day 6-10)
Tenascin-C induced during EMT S Maschler et al TN-C band of about 260 kDa in Western blots, while cellular extracts showed an additional, less intense band of 240 kDa (Figure 2c ). Using Swainsonine, a potent inhibitor of Golgi-associated a-mannosidase II and pulse chase labeling experiments, we could demonstrate that the 240 kDa form is a precursor of the mature fully glycosylated 260 kDa protein (data not shown).
Regulation of tenascin-C production and secretion by oncogenic Ras and TGFb
We next investigated the role of Ras in the regulation of TN-C expression, using EpH4 cells overexpressing oncogenic v-Ha-Ras (EpRas, Oft et al., 1996; Figure 2a) . Northern blot analysis from 48 h subconfluent cultures showed that EpRas cells contained substantially higher levels of the 7.5 kb TN-C mRNA than parental EpH4 cells (Figure 2b ), which did not decrease in postconfluent cultures (not shown), in contrast to the results in EpH4 cells ( Figure 1 ). As shown by Western blot analysis of both cell lysates and culture medium, confluent EpRas cells (harvested after 4 d) expressed much more cytoplasmic TN-C protein than EpH4 cells at similar density. However, EpH4 cells but not EpRas cells also showed efficient secretion of TN-C, suggesting that Ras alone may interfere with the secretion of TN-C.
In other cell types, TGFb1 causes upregulation of TN-C (Chiquet-Ehrismann et al., 1989; Rettig et al., 1994) , thus linking TN-C to changes in cell phenotype and migration induced by TGFb1 (scattering, EMT) in various cell types Portella et al., 1998; Janda et al., 2002a, b) . We therefore asked, how induction of EMT in EpRas cells, leading to cells with a mesenchymal, migratory phenotype (FibRas), would affect expression and secretion of TN-C. FibRas expressed similar amounts of TN-C mRNA as EpRas cells (Figure 2b ), but showed a strong upregulation of secreted TN-C. They also displayed less cytoplasmic TN-C, probably as a consequence of enhanced secretion (Figure 2c ). To test directly the effect of TGFb1 on TN-C expression and secretion, EpH4-derived cells were cultivated in the presence or absence of TGFb1 for 1-2 days, and analysed for both TN-C mRNA and protein expression. TGFb1 enhanced the expression of TN-C in all three cell lines, both at the mRNA ( Figure 3a ) and the protein level (Figure 3b ). Strikingly, TGFb1 strongly induced EpRas cells to secrete TN-C, while FibRas cells secreted the bulk of their TN-C in the presence or absence of exogenous TGFb1 (Figure 3b ), most likely due to autocrine TGFb1 production. In the parental EpH4 cells, TGFb1 upregulated cytoplasmic TN-C protein, while TN-C secretion remained constant (Figure 3b ). In conclusion, oncogenic Ha-Ras upregulates TN-C mRNA and protein expression in EpH4 cells, while efficient secretion of TN-C requires both oncogenic Ras and exposure to TGFb1.
Ras-induced tenascin-C upregulation requires the ERK/ MAPK but not the PI3K pathway Ha-Ras activity and stability depends on membrane anchorage, provided by farnesylation and geranylgeranylation of the C-terminal cysteine. Nontoxic farnesylcysteine mimetics (e.g. S-trans,trans-farnesylthiosalicyclic acid, FTS) dislodge Ha-Ras from the plasma membrane and thus inhibit its oncogenic activity (Haklai et al., 1998) . EpRas cells were treated with 10 and 25 mM FTS for 24 h, which led to a marked reduction of phosphorylated ERK1/2. Likewise, FTS-treatment downregulated TN-C protein as revealed by immunoprecipitation analysis (Figure 4a ). Activated Ras signals through two major downstream pathways, the ERK/MAPK-and the PI3K pathway (Downward, 1998) , which differentially contribute to epithelial cell motility, epithelial plasticity, apoptosis protection, tumor growth and metastasis (Potempa and Ridley, 1998; Bakin et al., 2000; Chen et al., 2000; Janda et al., 2002a, b) . To determine which of these Rasdownstream pathways were important for HaRas-dependent induction of TN-C mRNA and protein, we used (i) the MEK1 inhibitor PD98059 and the PI3K inhibitor LY294002 and (ii) two effector loop mutants in oncogenic V12-Ras, V12S35 and V12C40, which selectively hyperactivate the ERK/MAPK pathway or PI3K signaling, respectively (Downward, 1998; Janda et al., 2002a) . In EpRas cells, 50 mM PD98059 but not 50 mM LY294002 reduced the elevated phospho-ERK1/2 activity to basal levels ( Figure 4b ). In the same cells, 6 h of treatment with 50 mM PD98059 strongly reduced the levels of TN-C mRNA ( Figure 4c ) and protein expression, while 50 mM LY294002 hardly affected TN-C mRNA and protein levels even after 24 h ( Figure  4b, d) . Thus, TN-C upregulation by Ha-Ras requires a hyperactive ERK/MAPK pathway but not elevated PI3K signaling.
Equivalent results were obtained in EpH4 cells expressing Ras-effector domain mutants. Parental EpRas and the V12S35 mutant (hyperactivating ERK/ MAPK signaling) induced highly elevated levels of TN-C mRNA and protein expression (Figure 5a , b), whereas hyperactivation of the PI3K pathway in V12C40 cells hardly affected TN-C protein levels ( Figure 5b ) as compared to parental EpH4 cells (not shown). In conclusion, the ERK/MAPK pathway is both necessary and sufficient for Ras-dependent, elevated TN-C mRNA and protein expression in EpH4-derived cells.
To determine whether Ras-induced, hyperactive ERK/MAPK signaling is also critical for TN-C expression in other epithelial cell types, we compared ERK1/2 activities and TN-C expression before and after Ras transformation in two mammary-and prostate carcinoma-derived rat cell lines (RMCI, AT2.1). Both Rastransformed sublines expressed similar levels of Ha-Ras protein as EpRas control cells ( Figure 6 ). In the RMCI cells, Ha-Ras induced both elevated phospho-ERK levels and strongly enhanced TN-C levels, while HaRas induced neither TN-C expression nor elevated phospho-ERK in the AT2.1 cells. This confirms that TN-C expression requires elevated signaling through the ERK/MAPK pathway. Finally, we tested whether activation of endogenous signaling pathways causing transient activation of ERK1/2 could also induce TN-C. This was clearly not the case, since confluent EpH4 cells treated for 24 h with EGF (25 ng/ml), with the tumor promoter PMA (10 ng/ ml) or with PDGF (10 ng/ml) transiently upregulated ERK1/2, but failed to show enhanced TN-C expression (data not shown).
Since the TN-C gene promoter contains binding sites for AP-1 transcription factor complexes, we addressed the question of whether Jun-kinase (JNK) is a positive regulator of TN-C expression. Phospho-JNK-levels were low in EpRas and FibRas cells and (nonspecific) stimulation of JNK activity with anisomycin or arsenite reduced rather than enhanced TN-C protein levels in EpRas and/or FibRas cells. Anisomycin and arsenite also activated p38 MAPK, which did not affect phospho-ERK levels, in contrast to its antagonistic effect in other systems (Shields et al., 2002) . In line with this, the observed, arsenite-induced inhibition of TN-C expression in EpRas and FibRas cells was not due to p38 MAPK activity, since we could not rescue TN-C expression with the p38 MAPK inhibitor SB203580 (data not shown). Therefore, the mechanisms by which arsenite and anisomycin suppress TN-C expression remain to be investigated.
Deposition of tenascin-C into the extracellular matrix in cells before and after EMT TN-C matrix deposition is stimulated by TGFb1 in vitro and in vivo, and is an important event during wound healing (Taipale et al., 1998; Hocevar et al., 1999) . We therefore analysed ECM deposition of TN-C in response to TGFb1, using EpH4-derived cells during induction of EMT and 'scattering' (Janda et al., 2002a) .
TN-C deposition, as analysed by immunofluorescence of nonpermeabilized cells cultivated on plastic dishes, was absent in the ECM of untreated EpH4 cells. In the same cells, TGFb1 induced abundant deposition of TN-C into a pericellular matrix, together with FN and perlecan (Figure 7a ). In contrast, EpRas cells assembled FN-filaments but did not form a TN-C-or perlecancontaining matrix even in the presence of 8 ng/ml TGFb1 (Figure 7b ). More surprisingly, FibRas cells failed to deposit TN-C in the ECM, although these cells secrete TN-C and produced an ECM containing both FN and perlecan even in the absence of TGFb1 (Figures 3b and  7c) . Therefore, oncogenic Ha-Ras not only prevents secretion but also interferes with ECM deposition of TN-C and its direct interaction with FN/perlecan, described in other cell systems (Chiquet-Ehrismann et al., 1991; Chung and Erickson, 1997) .
The role of Ras-downstream signaling pathways in TN-C matrix deposition was investigated using Raseffector mutant-expressing EpH4 cells. V12S35 cells failed to assemble a TN-C-containing matrix similar to EpRas cells (Figure 7b ). In contrast, V12C40 cells deposited TN-C into the ECM upon TGFb1 treatment, together with FN and perlecan, similar to EpH4 cells (Figure 7b ). Thus, Ras-dependent prevention of TN-C incorporation into the ECM might involve hyperactive ERK/MAPK signaling.
The lack of TN-C deposition in Ras-transformed cells was not due to downregulation of transglutaminase II (TGII), which crosslinks distinct ECM proteins (Akimov and Belkin et al., 2001) . TGII was equally expressed in EpH4, EpRas and FibRas cells as demonstrated by immunoprecipitation of surface-biotinylated TGII. Furthermore, extracellular TN-C was not degraded by matrix metalloproteases (MMPs), since the MMP inhibitor GM6001 failed to promote incorporation of TN-C into the ECM of EpRas and FibRas cells (data not shown).
TN-C exists as several isoforms that display different affinities to other ECM components or cell surface receptors (Chiquet-Ehrismann et al., 1991; Chung and Erickson, 1997) . We therefore employed two TN-C isoforms not detected in EpH4/EpRas cells, a large TN-C isoform (TNL, 330 kDa) containing all 15 FNIII repeats, and a small TN-C form (TNS, 220 kDa) lacking the alternatively spliced FNIII A-D domains. In other cell types, TNS binds preferentially to FN and perlecan, while TNL is secreted into the culture supernatant (Chiquet-Ehrismann et al., 1991; Chung and Erickson, 1997) . We therefore tested whether the ECM deposited by EpH4-derived cells incorporated TNS but not TNL. Confluent cultures of EpH4, EpRas and FibRas cells, grown in the absence of TGFb1 were exposed for 24 h to 50 mg/ml of purified TNS and TNL (Saginati et al., 1992;  see Materials and methods). As shown by immunofluorescence, the large TN-C isoform TNL failed to bind to the ECM in any of the cell types (Figure 8 ). In contrast, the short TN-C isoform TNS accumulated in a condensed, patchy manner around EpH4 cells and Deposition of a tenascin-C matrix in 3D-collagen gels Possible reasons why FibRas cells cultivated on plastic failed to incorporate secreted TN-C into the ECM matrix might be that cells either fail to produce the required TN-C isoforms or produce an incomplete ECM, lacking components required for TN-C binding. We showed earlier (Janda et al., 2002a) that EpRas or FibRas cells cultured in serum-free, three-dimensional (3D) collagen gels reflect the behavior of these cells in mouse tumors, while the same cells cultured on plastic do not. In 3D-collagen cultures, EpRas cells form branched, lumen-containing tubular structures consisting of fully polarized cells. Upon induction of EMT by TGFb1, these structures remodel into unordered strands and chords of migratory fibroblastoid cells within 4-6 days, similar to the structures formed by FibRas cells Janda et al., 2002a) . Staining of structures formed by EpRas and FibRas cells for TN-C after permeabilization showed the expected strong signals of intracellular TN-C (data not shown, see Figure 2 ). However, fixed but nonpermeabilized collagen gel structures from EpRas cells showed no TN-C staining. When EMT was induced in EpRas cells by 
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TGFb1 treatment for 5 days, however, the resulting spindle-like cells did deposit TN-C at their periphery ( Figure 9 ). FibRas cells showed prominent pericellular staining for TN-C regardless of the presence or absence of TGFb1, suggesting that the endogenous, autocrine TGFb1 was sufficient for TN-C deposition. In 2D plastic cultures, EpRas and EpRasS35 cells also failed to deposit two other ECM proteins, FN and perlecan, perlecan being absent even after TGFb1 treatment (Figure 7b ). Since TN-C directly interacts with FN and perlecan (Chiquet-Ehrismann et al., 1991; Chung and Erickson, 1997) and thus might require the presence of these ECM proteins for proper deposition, we analysed the matrix deposition of FN and perlecan in 3D-collagen cultures of EpRas cells before and after induction of EMT. Interestingly, EpRas cells forming lumen-containing organotypic structures in collagen gels (inset in Figure 9b ) indeed deposited both FN and perlecan into the basement membrane surrounding the organotypic structures, in case of perlecan also within some intercellular spaces (Figure 9b ). EpRas cells induced to undergo EMT by TGFb1 (as well as FibRas cells; data not shown) showed the typical network of FN fibers known from fibroblasts, while a (apparently increased) perlecan expression (also as a network of thin fibers) was observed at the cell surface of the migrating cells. These results suggest that EpRas cells synthesized a more complete ECM under 3D-collagen gel culture conditions, perhaps facilitating the deposition of TN-C during EMT.
High tenascin-C expression in tumor cells correlates with metastatic ability of EpH4 cells expressing Ras-or Raseffector-specific mutants
Earlier, we showed that EpH4 cells exhibiting hyperactive ERK/MAPK signaling due to expression of V12 or V12S35 Ras underwent EMT in mouse tumors, as shown by coexpression of vimentin in the epithelial tumor cells (identified by expression of basal cytokeratins), and formed lung metastases in nude mice (Janda et al., 2002a) . In contrast, V12C40 cells showing elevated PI3K signaling formed tumors but were unable to undergo EMT in vivo (lack of vimentin staining in the epithelial tumor cells) or metastasis (Janda et al., 2002a) . Using immunofluorescence, we therefore analysed TN-C expression in tumors generated by these cell types. In normal mouse mammary glands, TN-C was absent from the ductal epithelial cells, but restricted to the basement membrane and subbasement membrane zone, suggesting synthesis/deposition by adjacent myoepithelial cells (Figure 10a ). In the vimentin-positive tumors induced by EpRas and V12S35 cells, the tumor cells themselves expressed high levels of TN-C (Figure 10b, c) . This staining was somewhat patchy and not present in all regions of the tumor, in line with the fact that not all parts of an EpRas-induced tumor show vimentin/ cytokeratin costaining signifying EMT Janda et al., 2002a) . In contrast, tumors induced by V12C40 cells revealed no TN-C staining in the tumor cells, while the tumor vasculature showed strong staining for TN-C (Figure 10d) , as proven by costaining for the endothelial marker CD31 (data not shown). These results suggest that TN-C production and/or deposition correlates with EMT and metastatic ability in vivo and could be confirmed in spontaneous mouse tumors from MMTV-HER2-(no EMT) and MMTV-HER2 Â MMTV-TGFb1-transgenic mice (increased metastasis, EMT; see Discussion). Figure 9 EMT-associated deposition of a TN-C containing matrix in collagen gels. EpRas and FibRas cells were seeded into collagen gels and cultivated for 6 days, both in the presence and absence of TGFb1. Cells were then fixed but not permeabilized (see Materials and methods) and analysed for TN-C fluorescence by immunostaining and confocal microscopy (a, Janda et al., 2002a, b) using a DAPI counterstain (blue) to visualize nuclei (DNA). In addition, the hollow structures formed by EpRas cells cultivated in collagen gels in the absence of TGFb1 for 6 days (b; left panels, inset showing bright field image) or after TGFb1-induced EMT (b, right panels) were stained for FN and perlecan (see legend to Figure 7 ) and analysed by confocal microscopy (b). DAPI-stained nuclei, green
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Discussion
In the EpH4/EpRas model, EMT induced by the cooperation of oncogenic Ha-Ras with TGFb1 was shown to be a faithful in vitro correlate for local invasion and metastasis (Janda et al., 2002a; Oft et al., 2002; Grunert et al., 2003) . In this paper, we demonstrate that secretion and ECM incorporation of TN-C, a large ECM glycoprotein that modulates stromal-epithelial interactions, is tightly linked to EMT. We show that Ras-driven hyperactive ERK/MAPK signaling upregulates production of TN-C, while TGFb1 promotes its secretion upon induction of EMT. We also demonstrate that TN-C deposition into the ECM correlates with EMT, both in 3D-collagen cultures of EpRas cells and in mammary tumors.
Oncogenic Ras induces TN-C transcription while Ras plus TGFb1 causes its secretion
In EpH4 cells, TN-C is expressed as a single 7.5 kb mRNA, corresponding to a splice variant also found in HC11 cells (Wirl et al., 1995 (Carnemolla et al., 1992; Brenner et al., 2000) .
Ras-downstream signaling pathways involved in regulation of TN-C expression
Using both low-molecular-weight inhibitors of Mek-1 (PD98059) and PI3K (LY294002), as well as Ras-effector loop mutant proteins signaling either via the ERK/MAPK pathway (V12S35) or the PI3K pathway (V12C40), we showed that elevated ERK/ MAPK signaling but not PI3K signaling was required for high expression levels of TN-C. Similarly, hyperactive ERK/MAPK signaling was required for EMT in vitro and metastasis formation in vivo (Janda et al., 2002a) . Induction of TN-C-expression by elevated ERK/MAPK signaling also occurred in other tumor cell types, for example RMCI rat tumor cells, while AT2.1 tumor cells were unresponsive to oncogenic Ras, both with respect to enhanced phospho-ERK1/2 levels and upregulation of TN-C. In contrast, activation of endogenous ERK/MAPK signaling by ligandactivated receptor tyrosine kinases (EGF-R/PDFG-R) or by phorbol esters (PMA) was insufficient to upregulate TN-C in EpH4 cells. In line with this, treatment of EpH4 cells with very high TGFa levels (1 mg/ml) plus TGFb induced reversible scattering but not EMT (S Grunert, unpublished). Thus, EMT and TN-C induction share the requirement for hyperactive ERK/MAPK signaling, only inducible by oncogene action. Two other Ras effectors, JNK and p38 MAPK, were not Ras-induced in EpH4-derived cells, suggesting that these pathways are not required for TN-C induction. In other systems, transformation with oncogenic Jun represses TN-C while physiological, transient c-Jun activation stimulates TN-C expression (Mettouchi et al., 1997) . Artificial hyperactivation of JNK with anisomycin and arsenite suppressed rather than activated TN-C expression in EpH4-derived cells, particularly in FibRas cells. The mechanism of this suppression is unclear, but it is possible that the strong c-Jun activation caused by activated JNK might cause Fos to dimerize with binding partners other than c-Jun to form a Ras-induced, active AP1 transcription factor complex, which induces TN-C transcription in a Ras but not JNK-dependent manner. Janda et al., 2002a, b) were injected into the mammary gland fat pads of nude mice. After tumor development, tumor tissue was fixed and cryosections stained for TN-C by immunofluorescence. In (a), sections through normal mammary gland tissue were processed similarly. In these sections, TN-C appears as a thin continuous line in the subbasement membrane zone of most ductules but is absent from the epithelial cells
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EMT requires 3D-collagen gel cultures to mediate TN-C incorporation into the ECM TN-C binds to cell surface receptors such as annexin II and various integrins (Chung and Erickson, 1994; Jones and Jones, 2000a) and to ECM components such as FN and perlecan (Chung et al., 1995; Chung and Erickson, 1997) . In the mammary gland, TN-C was expressed in basement membranes of endothelial cells and between myoepithelial and luminal epithelial cells (Figure 10a ; S Grunert, unpublished) . In line with its well-known ability to induce secretion and deposition of ECM proteins (Taipale et al., 1998; Hocevar et al., 1999) , TGFb1 induced normal EpH4 cells to deposit TN-C into extracellular, mostly fibrillar structures, also containing FN and perlecan. Surprisingly, EpH4-derived cells exhibiting a hyperactive ERK/MAPK pathway (EpRas, V12S35 and FibRas) all failed to incorporate TN-C into the ECM, even in the presence of TGFb1, while V12C40 cells showing basal ERK/MAPK activity were able to deposit TN-C upon TGFb1 treatment, together with perlecan and FN. Control experiments showed that this was neither due to downregulation of tissue transglutaminase (required for ECM protein crosslinking) nor the activity of MMPs.
A clue to explain these puzzling results was obtained by analysing EpRas-derived cell types forming organotypic structures in 3D-collagen gel cultures for ECM deposition of TN-C and other matrix proteins. Under these conditions, EpRas cells still failed to secrete TN-C, while FibRas cells and EpRas cells induced to undergo EMT by TGFb1 treatment secreted and deposited TN-C into extracellular material, in contrast to our findings in 2D cultures. We observed earlier that EpH4 and EpRas cell structures were surrounded by a thick basement membrane containing most of the known ECM proteins, including laminins (S Grunert, unpublished) . In line with this, the basement membranes of EpRas-derived organotypic structures did contain both FN and perlecan, in contrast to the respective cells in 2D cultures. After TGFb1-induced EMT, both FN and perlecan redistributed into a fibril network at the cell surface of the migrating cells, probably facilitating TN-C deposition during EMC remodeling. Thus, in 2D plastic but not in 3D cultures, a hyperactive ERK/ MAPK pathway might interfere with the synthesis or secretion of certain ECM proteins required for ECM deposition of TN-C.
Elevated TN-C production/matrix deposition: important for tumor progression in vivo?
We showed that overexpression of TN-C in tumors induced by Ras-or Ras mutant-expressing EpH4 cells fully coincided with the ability of the respective tumor cells to undergo EMT in vivo and to form metastases upon tail vein injection. In tumors induced by EpH4 cells transformed by V12 or V12S35 Ras the tumors cells themselves expressed TN-C, while in V12C40 Rasinduced tumors TN-C was restricted to the walls of blood vessels, and not observed in the tumor cells.
Similar results were obtained in a transgenic mouse tumor model, that is mice expressing HER2 or both HER2 and TGFb1 under control of the MMTV promoter (Siegel et al., 2003 ). As will be described elsewhere (Grunert et al., in preparation) , the HER2 plus TGFb1 expressing tumors underwent EMT and expressed TN-C in the vimentin-positive tumor cells, while the HER2-induced tumor cells showed neither EMT nor TNC expression, where its expression was restricted to the blood vessel wall.
TN-C overexpression occurs in many human cancers (Jones, 2001) , in line with the high frequency of oncogenic Ras mutations (Bos, 1989; Webb et al., 1998; Ward et al., 2001) . Oncogenic Ha-Ras plus TGFb1, shown to cause TN-C secretion and matrix deposition in correlation with EMT and tumor progression in our models (Oft et al., 1998; Janda et al., 2002a, b) , also cooperate in other in vivo models, such as in tumors induced by keratinocytes (Cui et al., 1996; Weeks et al., 2001; Oft et al., 2002) and mammary epithelial cells (Muraoka et al., 2002; Yang et al., 2002) . It remains open, however, if and how upregulation of TN-C might contribute to migration, local invasion and metastasis.
One possible function of TN-C might be enhanced angiogenesis, for instance via activation of integrins avb3 and a2b1, which are important for migration and proliferation of endothelial cells (Jones and Jones, 2000a; Zagzag et al., 2002) . Indeed, TN-C production by invasive human breast carcinomas was associated with angiogenesis (Tokes et al., 1999) . In line with this, enhanced expression of TN-C at the invasive edges of glioblastomas was found to be closely associated with vascular sprouts (Zagzag et al., 2002) .
What could be the role of TN-C produced by the tumor cells themselves? Firstly, the EGF-like repeats of TN-C might strongly activate EGF receptors on neighboring tumor cells and thus directly promote cell proliferation and migration of cancer cells (Swindle et al., 2001) . Secondly, tumor cell-associated TN-C might activate avb3 integrins on neighboring breast carcinoma cells, again resulting in increased proliferation and cell migration (Brooks et al., 1995; FeldingHabermann et al., 2001) . Since oncogenic Ras induces both TN-C and avb3 integrin (Woods et al., 2001; Oft et al., 2002) , TN-C-driven integrin signaling could be particularly relevant in tumors with high ERK/MAPK signaling.
Finally, the contribution of TGFb1 overexpression in tumor cells and tumor stroma (Oft et al., , 1998 to invasion and metastasis of carcinomas (for a review, see Akhurst and Derynck, 2001; Akhurst, 2002) could critically involve TN-C signaling. During EMT/tumor progression, TGFb1 plus oncogenic Ras induce not only TN-C itself but also upregulate metalloproteinases including MMP2 (Moon et al., 2000; Jechlinger et al., 2003) , which could make secreted TN-C available to stromal and endothelial cells through basement membrane degradation. And finally, TGFb1 might induce TN-C in stromal fibroblasts, in turn stimulating proliferation and migration of tumor cells (ChiquetEhrismann et al., 1989).
In conclusion, the coregulation of TN-C gene expression, protein secretion and matrix deposition by Ras and TGFb1 is likely to contribute strongly to the development of more aggressive tumor phenotypes, both by accelerating angiogenesis and by promoting tumor cell proliferation and invasion.
Materials and methods
Cells and cell culture
The EpH4-derived cell types EpH4, EpRas, V12S35 cells, V12C40 cells and FibRas were described previously (Reichmann et al., 1992; Oft et al., 1996; Janda et al., 2002a) . The rat mammary and prostate tumor cell lines RMCI, and AT2.1 and respective v-Ha-Ras transformants were obtained from JT Isaacs (John Hopkins University, Baltimore, MD, USA). All cells were grown in Dulbecco's modified Eagle's medium (DMEM), supplemented with 8% heat-inactivated fetal bovine serum (FCS, Gibco BRL, Painsley, UK), 2 mM L-glutamine, 10 mM HEPES pH 7.0, and 2 mM penicillin/streptomycin (Sigma-Aldrich, Vienna, Austria), subculturing them at a ratio of 1 : 3 twice a week.
3D collagen gel cultures of EpH4 cells and their transformed derivates were performed as described previously (Janda et al., 2002a) .
Reagents and antibodies
Recombinant TGFb1, TNF-a and PDGF-BB were obtained from R&D systems. EGF, PMA and LY294002 were purchased from Sigma-Aldrich. Rat recombinant HGF was from T Nakamura (Osaka University, Osaka, Japan). The metalloproteinase inhibitor GM6001 was purchased from Chemicon. SB203580 and PD98059 were obtained from Calbiochem (San Diego, CA, USA) and New England Biolabs, respectively.
Activated MAP-kinases were identified using phosphospecific polyclonal antibodies against ERK1/2, p38 MAPK (New England Biolabs) and SAPK/JNK (Promega). Antibodies detecting total ERK1/2 were from New England Biolabs (9100). Anti-Ha-Ras antibody was from Santa Gruz Biotechnology. Goat polyclonal antibodies against transglutaminase type II were from Upstate Biotechnology. Antibodies recognising FN (Dakopats, Glostrup, Denmark) and perlecan (a gift from R Timpl, MPI of Biochemistry, Munich, Germany) were used in immunofluorescence studies. Polyclonal antibodies directed against human TN-C were provided by H Erickson (Duke University, Durham, NC, USA). Anti-b-Actin was from Boehringer Mannheim. Larger and smaller TN-C isoforms purified from the conditioned media of human melanoma cell line SK-MEL 28 were obtained from L Zardi (University of Genova, Italy). Anisomycin and sodiumm-arsenite were from Sigma-Aldrich. The Ras antagonist FTS (Jansen et al., 1999 ) was a gift from B Jansen, University of Vienna, Austria.
Immunofluorescence
Cells were fixed in PBS-buffered 4% paraformaldehyde and exposed to primary antibodies diluted in PBS plus 0.1% BSA for 1 h at room temperature, followed by FITC-conjugated goat anti-rabbit IgG (1 : 100, Chemicon) as secondary antibody. For intracellular staining, cells grown on plastic were fixed and permeabilized with methanol for 10 min on ice.
Collagen gels and fixed tumor tissues were fixed and stained as previously described (Janda et al., 2002a, b) .
Western blot analysis
Conditioned media were collected and centrifuged for 5 min at 12 500 g at 41C. In parallel, cells cultured on 35 mm dishes were washed with PBS, lysed for 20 min in ice-cold lysis buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1% NP40, 1% sodiumdeoxycholate, 1 mM EDTA, 1 mM Na 3 VO 4 , 25 mM NaF, 1 mM PMSF and 10 mg/ml aprotinin) and cleared by centrifugation as above. In all, 40 mg cellular protein (determined by the Biorad protein assay) and/or 20 ml conditioned medium were denatured in SDS-sample buffer, followed by SDS-PAGE and transferred onto nitrocellulose membranes (Amersham, UK). Membranes were blocked in TBST (10 mM Tris-HCl pH 7.4, 150 mM NaCl, and 0.1% Tween 20) plus 5% skimmed milk at 41C overnight and incubated with primary antibodies for 1 h, or overnight at 41C to detect Ha-Ras, pERK1/2, pp38 MAPK and pJNK by phosphospecific antibodies. Membranes were washed with TBST, incubated with peroxidase-conjugated secondary antibodies (sheep anti rabbit IgG, Amersham, 1 : 1000 in TBST) and visualized using an enhanced chemiluminescence kit (ECL, Amersham).
Immunoprecipitation of surface-labeled proteins
Cell surface biotinylation was performed as described previously (Defilippi et al., 1997) . Briefly, cells were biotinylated with 1 mg/ml Sulfo-NHS-Biotin (Sigma), washed with Hank's solution, biotinylated again and washed with DMEM containing 0.6% BSA. Cells were extracted with 50 mM Tris (pH 7.5), 0.1% Triton-X-100 and 150 mM NaCl plus protease inhibitors. Equal amounts of protein were immunoprecipitated with the indicated antibody. Protein-A-Sepharose (50% w/v, SigmaAldrich) was added for 2 h, and precipitates were washed and processed for SDS-PAGE. After electrophoresis, samples were Western-blotted and biotinylated proteins were detected with streptavidin-HRP and exposed to luminol substrate.
Immunoprecipitation of metabolically labeled proteins
Cells were preincubated with methionine and cysteine-free MEM (Life technologies) for 1 h, labeled with 100 mCi of L- (S 35 ) methionine and cysteine (Trans 35 S-label, ICN, Costa Mesa, CA, USA) for 5 h and lysed as described above. Aliquots of cell lysates cleared by centrifugation and containing 1-2 Â 10 6 c.p.m. of incorporated S 35 were incubated with the appropriate antibody overnight at 41C. Immunocomplexes were precipitated with protein-A-Sepharose (50% w/v, SigmaAldrich) and washed sequentially with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 0.1% BSA, Tris-HCl plus 150 mM NaCl and Tris-HCl. Precipitated proteins were then processed for SDS-PAGE. Gels were fixed, treated with Amplifier (Amersham) and exposed for autoradiography.
Cellular RNA isolation and Northern blot analysis
RNA isolation was performed according to Chomczynski and Sacchi (1987) . Total RNA (10 mg/lane) was run on 7% formaldehyde-containing 1% agarose gels and then blotted onto an amphoteric 6.6 nylon membrane (Pall corporation). cDNA probes were prepared from the following cDNA fragments: mouse TN-C p5 0 6 corresponding to the 5 0 region (Weller et al., 1991) ; human FN spanning the 5 0 region of the human FN gene and the 3 0 UTR; and mouse TGFb1 (gift from E Reichmann). The probes were labeled with 32 P-dATP using Tenascin-C induced during EMT S Maschler et al the randomly primed DNA labeling method. A cDNA for human GAPDH was used as loading control.
Tumor induction
Cells to be injected were trypsinized, washed in PBS and 1 Â 10 5 cells in 25 ml PBS were injected into the mammary gland fat pad of Avertin anesthetized MF1 nu/nu mice (Charles River WIGH, GmbH). Mice were killed after 3 weeks, the tumors were dissected and fixed in 4% PFA for 24 h, followed by 20% sucrose for further 24 h, and processed for preparation of frozen sections.
